Event Details
Verastem Inc at 2013 International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer
Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of VS-6063 as Maintenance Therapy in Subjects with Malignant Pleural Mesothelioma which has Not Progressed on at least 4 Cycles of Pemetrexed/Platinum Therapy (COMMAND)
Abstract #:
P2.14-014
Date and Time:
Tuesday, October 29, 2013 9:30 – 4:30 PM
Session:
Poster Session 2; Mesothelioma
Location:
Exhibit Hall, Ground Level
Title:
Malignant Mesothelioma Lacking Merlin Shows Enhanced Sensitivity to the FAK Inhibitor VS-6063: Evaluation of Merlin/NF2 Status in Clinical Samples
Abstract #:
P2.06-048
Date and Time:
Tuesday, October 29, 2013 9:30 – 4:30 PM
Session:
Poster Session 2; Prognostic and Predictive Biomarkers
Location:
Exhibit Hall, Ground Level